#PC3IatASCO: Emily Ko, Anna Jo Smith & @guerraviswanath.bsky.social evaluated implementation of a patient-ambassador program to provide #GynecologicOncology clinical trial awareness & knowledge for patients.

#ASCO25 @ascocancer.bsky.social
meetings.asco.org/ab...

#PC3IatASCO: PC3I's Melina Marmarelis, Charu Aggarwal & team used an EMR-based nudge for #NSCLC molecular testing at time of 1st post-operative visit. Findings showed the nudges increased rate of #moleculartesting in patients.

#ASCO25 #LungCancer #LCSM
meetings.asco.org/ab...

#PC3IatASCO: Susan Domchek w/ PC3I's Kate Rendle & Peter Gabriel implemented nudges to increase #genetictesting for diverse populations of patients at risk for #breastcancer and #ovariancancer across @pennmedicine.bsky.social.

#ASCO @ascocancer.bsky.social
meetings.asco.org/ab...

#PC3IatASCO: Lauren Hamel, David Dougherty & team testing the effectiveness of using a education & communication intervention app to mitigate #financialtoxicity in patients with #cancer.

#ASCO25 @ascocancer.bsky.social
meetings.asco.org/ab...

pc3i.upenn.edu/news/...

#PC3IatASCO: PC3I's Allie Barz Leahy, Haley Newman, & ‪@kerrycoughlin.bsky.social‬ analyzed pt & caregiver-reported #financialtoxicity (FT) outcomes for #pediatric pts receiving CAR T therapy & found high prevalence of FT at time of infusion.

#ASCO25

meetings.asco.org/ab...

#PC3IatASCO: Surbhi Grover & Katie Lichter compared the #environmental impacts of #radiotherapy in Brazil and external beam #radiation therapy in the U.S.; and explored how sustainable practices can promote equity & expand access.

#ASCO25 @ascocancer.bsky.social
meetings.asco.org/ab...

#PC3IatASCO: @gabealeixo.bsky.social, @rsedhom.bsky.social & Sam Takvorian evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer.

#ASCO25 @ascocancer.bsky.social
meetings.asco.org/ab...